Roivant Sciences Ltd (ROIV)

Oct 01, 2026

Form 144 Roivant Sciences Ltd. For: 1 October By Investing.com - Investing.com Canada

Oct 01, 2026

Sep 30, 2026

Roivant Sciences Ltd. (ROIV) Stock Forecasts - Yahoo! Finance Canada

Sep 30, 2026

Sep 30, 2026

After a $7.15M August sale, Roivant (ROIV) officer Eric Venker proposes another share sale. - Stock Titan

Sep 30, 2026

Sep 30, 2026

Roivant Sciences Ltd. (ROIV) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 30, 2026

Sep 29, 2026

Roivant Sciences Ltd (ROIV) Stock Price Target & Forecast - TradingKey

Sep 29, 2026

Sep 28, 2026

Roivant Sciences gains as investors appear to keep rewarding recent clinical and regulatory momentum - Quiver Quantitative

Sep 28, 2026

Sep 28, 2026

Roivant Sciences Targets LISRAYA Launch, Key Pipeline Readouts in Next 12 Months - Yahoo Finance

Sep 28, 2026

Sep 28, 2026

Form 4 Roivant Sciences Ltd. For: 28 September By Investing.com - Investing.com Nigeria

Sep 28, 2026

Sep 25, 2026

Bernstein Initiates Roivant Sciences(ROIV.US) With Buy Rating, Announces Target Price $41 - Moomoo

Sep 25, 2026

Sep 24, 2026

Roivant Sciences Ltd. (ROIV) stock price, news, quote and history - Yahoo Finance Singapore

Sep 24, 2026

Sep 24, 2026

Roivant’s Lung Drug Clears Phase 2 Test: Is Another Major Pipeline Asset Emerging? - Yahoo Finance

Sep 24, 2026

Sep 24, 2026

Cantor Fitzgerald reiterates Roivant Sciences stock rating By Investing.com - Investing.com Canada

Sep 24, 2026

Sep 23, 2026

ROIV Looks 361.0% Overvalued on GF Value™ - GuruFocus

Sep 23, 2026

Sep 23, 2026

Why Is Immunovant Stock Falling Wednesday?Roivant Sciences (NASDAQ:ROIV), Immunovant (NASDAQ:IMVT) - Benzinga

Sep 23, 2026

Sep 23, 2026

Roivant’s Immunovant Stops IMVT-1402 Development in Cutaneous Lupus After Trial Miss - Yahoo Finance

Sep 23, 2026

Sep 23, 2026

Roivant slips on trial setback for Immunovant (ROIV:NASDAQ) - Seeking Alpha

Sep 23, 2026

Sep 23, 2026

A skin-lupus drug study missed its main goal. Its developer plans to stop testing it. - Stock Titan

Sep 23, 2026

Sep 23, 2026

Behavioral Patterns of ROIV and Institutional Flows - Stock Traders Daily

Sep 23, 2026

Sep 22, 2026

Roivant (ROIV) CAO uses 3,880 shares to cover RSU taxes - Stock Titan

Sep 22, 2026

Sep 22, 2026

Form 4 Roivant Sciences Ltd. For: 22 September By Investing.com - Investing.com Australia

Sep 22, 2026

Sep 22, 2026

Roivant Sciences (ROIV) CFO now holds 269,681 shares after RSU tax withholding - Stock Titan

Sep 22, 2026

Sep 22, 2026

Why Roivant Sciences (ROIV) Is Back In The Spotlight - simplywall.st

Sep 22, 2026

Sep 22, 2026

Transcript : Roivant Sciences Ltd. Presents at Bank of America Global Healthcare Conference 2026, Sep-22-2026 12 - marketscreener.com

Sep 22, 2026

Sep 22, 2026

Roivant (ROIV): $9 Billion Sales Potential Faces a Commercialization Test - Yahoo Finance

Sep 22, 2026

Sep 21, 2026

Roivant Sciences Ltd. (ROIV) Stock Analysis: Analyzing a 20% Potential Upside Amid Biotech Innovation - DirectorsTalk Interviews

Sep 21, 2026

Sep 19, 2026

Did Positive PH ILD Trial Data Just Shift Roivant Stock Investment Narrative? - simplywall.st

Sep 19, 2026

Sep 18, 2026

Roivant Sciences (ROIV) director receives new 2027-vesting equity grant - Stock Titan

Sep 18, 2026

Sep 18, 2026

Roivant Sciences (ROIV) director now holds 8.97M shares - Stock Titan

Sep 18, 2026

Sep 18, 2026

New stock awards for Roivant Sciences (ROIV) director vest in 2027 - Stock Titan

Sep 18, 2026

Sep 18, 2026

Roivant Sciences (ROIV) grants director stock awards vesting in 2027 - Stock Titan

Sep 18, 2026

Sep 18, 2026

Roivant Sciences (ROIV) gives director new options and RSUs - Stock Titan

Sep 18, 2026

Sep 18, 2026

Director at Roivant (ROIV) receives new stock awards - Stock Titan

Sep 18, 2026

Sep 18, 2026

What Is Roivant Sciences (ROIV) Signaling With Its Positive PH ILD Trial Data? - Yahoo Finance

Sep 18, 2026

Sep 17, 2026

Director Melissa Epperly Sells 4,938 Shares of Roivant Sciences Ltd (ROIV) - gurufocus.com

Sep 17, 2026

Sep 17, 2026

Roivant Sciences (NASDAQ: ROIV) director sells 4,938 shares under 10b5-1 plan - Stock Titan

Sep 17, 2026

Sep 17, 2026

Roivant Sciences (ROIV) director sells 5,112 shares under pre-set plan - Stock Titan

Sep 17, 2026

Sep 17, 2026

ROIV Initiates Coverage by Stifel -- Price Target Announced at $51 - GuruFocus

Sep 17, 2026

Sep 17, 2026

Roivant Sciences Price Target Announced at $51.00/Share by Stifel - Moomoo

Sep 17, 2026

Sep 17, 2026

Stifel Initiates Roivant Sciences(ROIV.US) With Buy Rating, Announces Target Price $51 - Moomoo

Sep 17, 2026

Sep 16, 2026

Stifel initiates Roivant Sciences stock with buy rating, $51 target By Investing.com - Investing.com South Africa

Sep 16, 2026

Sep 16, 2026

Stifel initiates Roivant Sciences stock with buy rating, $51 target - Investing.com

Sep 16, 2026

Sep 15, 2026

Roivant Sciences (ROIV) director lines up $930K stock sale - Stock Titan

Sep 15, 2026

Sep 15, 2026

Roivant Sciences (NASDAQ: ROIV) officer to sell 5,112 shares - Stock Titan

Sep 15, 2026

Sep 15, 2026

Why Roivant Sciences (ROIV) Stock Is Down Today - Quiver Quantitative

Sep 15, 2026

Sep 15, 2026

Roivant Sciences Director Melissa B. Epperly Forfeits 2,179 Shares at $40.94 Each (NASDAQ: ROIV) - Kalkine Media

Sep 15, 2026

Sep 14, 2026

Roivant Sciences (ROIV) director uses shares to cover tax bill - Stock Titan

Sep 14, 2026

Sep 14, 2026

Roivant Sciences (ROIV) director uses stock to cover tax bill - Stock Titan

Sep 14, 2026

Sep 14, 2026

Roivant Sciences Ltd. (ROIV) Stock Analysis: High Analyst Confidence with a 12.58% Upside Potential - DirectorsTalk Interviews

Sep 14, 2026

Sep 14, 2026

Roivant Sciences (ROIV) director uses shares to cover taxes - Stock Titan

Sep 14, 2026

Sep 13, 2026

ROIV gains commercial footing with LISRAYA appr... - Pluang

Sep 13, 2026

Sep 13, 2026

Roivant Sciences: Diverse Exposure To Biotech Niches Through Vants (NASDAQ:ROIV) - Seeking Alpha

Sep 13, 2026

Sep 13, 2026

Roivant Sciences Ltd. (ROIV)’s Pulmonary Hypertension Breakthrough Could Transform Its Growth Story - Yahoo Finance

Sep 13, 2026

Sep 12, 2026

(ROIV) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Sep 12, 2026

Sep 12, 2026

Roivant Sciences (ROIV) Could Be 308% Overvalued Following Phase 2 Mosliciguat Data - simplywall.st

Sep 12, 2026

Sep 12, 2026

ROIV Stock Nears Record High –Retail Traders See Breakout After Surprise Earnings Beat - Stocktwits

Sep 12, 2026